Chairperson – Anka G. Ehrhardt – Director, Cell-Based Sciences – Merck

PROGRAM
Enabling Precision Medicine In Respiratory and Immunology
Daniel Muthas – Head of Data Science & Bioinformatics in Translational Science & Experimental Medicine, in Early Respiratory & Immunology – AstraZeneca
Precision Medicine Through the Single-cell Lens
Virginia Savova – Senior Director, Global Head of Single-cell Biology – Sanofi
The Value of Community-led, Open Innovation to Unlock Personalized Healthcare
Michael Duong – Head of Innovation – Roche
Compelling Case Studies in Anti-virals and Oncology Demonstrate use of Machine Learning to Advance Precision Medicine
Subha Madhavan – VP & Head of Clinical AI/ML, Early Clinical Development, Worldwide R&D – Pfizer
Driving the Implementation of Precision Medicine and Diagnostics in Chronic Diseases
Karsten Nielsen – Scientific Diagnostic Director, Translational Development – Novo Nordisk
Precision Medicine is Also a Matter of Partnership
Gabriele Allegri – Global Commercial Head – Precision Medicine – Janssen Inc.
Panel Discussion
Implementing Biomarker Strategy in Clinical Trials
Chetan Deshpande – Director Biomarker Clinical Lead – Pfizer
Patient Access to Testing and the Promise of Precision Medicine
Jennifer Quigley – Sr. Director Global Precision Medicine, Hematology – Novartis

• 1-year access to the recorded version
• This event was sponsored by lifespin GmbH, a next-generation platform for affordable precision medicine.